Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 19.99.
Forward PE Ratio (19.99) = Close Price ($255.62) / Consensus Forward EPS ($12.97)
FORWARD PE RATIO
19.99
SECTOR MEDIAN · HEALTHCARE
19.84
median of 78 covered companies
CURRENT VS SECTOR MEDIAN
+0.78%
vs the sector median at left
IQVIA Holdings Inc.
Market Cap
$42.08B
Forward PE Ratio
19.99
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| IQVIA Holdings Inc. (IQV) | $42.08B | 19.99 |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $42.87B | 18.55 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $41.12B | 35.22 |
| Agilent Technologies, Inc. (A)vs › | $40.84B | 23.68 |
| Humana Inc. (HUM)vs › | $47.87B | 44.03 |
| Becton, Dickinson and Company (BDX)vs › | $49.64B | 14.14 |
| Edwards Lifesciences Corporation (EW)vs › | $49.89B | 28.90 |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $34.17B | 38.72 |
| Alcon Inc. (ALC)vs › | $33.65B | 19.80 |
| DexCom, Inc. (DXCM)vs › | $32.08B | 31.69 |
Trailing P/E
32.2
reported TTM EPS
Forward P/E
20.0
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $12.97 implies +60.9% EPS growth vs the reported trailing $8.06.
At today's $255.62 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $12.97 | $12.92 – $13.03 | 14 | 19.7x |
| 2027-12-31 | $14.42 | $13.99 – $15.11 | 14 | 17.7x |
| 2028-12-31 | $16.15 | $14.03 – $18.67 | 9 | 15.8x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute